Suchergebnisse - "Addington, Jean"

PubPharm (556)

1

Harmonizing the structured interview for psychosis-risk syndromes (SIPS) and the comprehensive assessment of at-risk mental states (CAARMS) : An initial approach

enthalten in: Early intervention in psychiatry | 2024

von Addington, J. | Woods, S. | Yung, A. | +2

2

Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

enthalten in: Early intervention in psychiatry | 2024

von Woods, S. | Parker, S. | Kerr, M. | +119

UpdateOf: medRxiv. 2023 May 02;:. - PMID 37205422

3

Race/ethnicity and socioeconomic status as predictors of outcome following family therapy in youth at clinical high risk for psychosis

enthalten in: Early intervention in psychiatry | 2024

von Ruiz-Yu, B. | Le, T. | Weintraub, M. | +11

4

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

enthalten in: bioRxiv.org | 2024

von Woods, S. | Parker, S. | Kerr, M. | +81

5

The hierarchical taxonomy of psychopathology in clinical high risk for psychosis : Validation and extension

enthalten in: Journal of psychopathology and clinical science | 2024

von Williams, T. | Williams, A. | Cowan, H. | +12

6

Introduction to the special issue

enthalten in: Early intervention in psychiatry | 2024

von Addington, J. | Nelson, B.

7

Unique functional neuroimaging signatures of genetic versus clinical high risk for psychosis

enthalten in: bioRxiv.org | 2024

von Schleifer, C. | Chang, S. | Amir, C. | +25

8

Plasma complement and coagulation proteins as prognostic factors of negative symptoms : An analysis of the NAPLS 2 and 3 studies

enthalten in: Brain, behavior, and immunity | 2024

von Byrne, J. | Healy, C. | Föcking, M. | +18

9

Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms

enthalten in: Brain, behavior, and immunity | 2024

von Healy, C. | Byrne, J. | Raj Suasi, S. | +17

10

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) : Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

enthalten in: Schizophrenia bulletin | 2024

von Wannan, C. | Nelson, B. | Addington, J. | +98

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[56]